Screener
Calidi Biotherapeutics CLDI Q3 2025 earnings
Reported November 13, 2025 · Before market open
EPS-$2.21Miss by $0.53
EPS estimate-$1.68
Next report
Nov 17, 2026 (in 2 months)Versus estimates
Diluted EPS
Q2 2026-$2.94Q1 2026-$0.43Q4 2025-$0.57Beat by $0.99
Q3 2025-$2.21Miss by $0.53
Q2 2025-$1.99Miss by $0.07Q1 2025-$2.16Miss by $2.01FAQ
- When did Calidi Biotherapeutics report Q3 2025 earnings?
- Calidi Biotherapeutics (CLDI) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were Calidi Biotherapeutics's Q3 2025 revenue and EPS?
- Calidi Biotherapeutics reported eps of $-2.21 for Q3 2025.
- Did Calidi Biotherapeutics beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-1.68 by $0.53.
- How did Calidi Biotherapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 71.7% from $-7.80.
- Where can I find Calidi Biotherapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-25-021418) and the 10-Q periodic report (0001493152-25-022372) directly on SEC EDGAR. The filing index links above go to sec.gov.
